Net earnings per share (EPS TTM): Hoth (HOTH)

Symbol and logo of brand hoththerapeutics.com (HOTH)

This 12-month net income per share chart on GURU.Markets demonstrates earnings dynamics, where the value of -0.81 corresponds to the current metric. Hoth Therapeutics, Inc. (HOTH) growth is based on the promotion of psoriasis treatments and the licensing potential of its patents. The operating model relies on contract manufacturing of formulas. The speculative nature of the developments and the anticipation of onco-gel data are already priced into the quotes.

HOTH Hoth Earnings per share for the last 12 months (07/04/2022 - 05/28/2026)

Analytical breakdowns and data insights for company hoththerapeutics.com (HOTH)

- company stock exchange capitalization indicators:
Summary company analytics:Hoth (HOTH)
Mass-produced product of Hoth Therapeutics, Inc.

Fundamental analysis requires an accurate assessment of returns to minimize investment risks. Hoth Therapeutics, Inc. (HOTH) is characterized by a lack of revenue and systematic capital burn on R&D projects. Net income per share for the trailing 12 months is calculated by dividing total profit by the total number of securities. This chart reflects the actual value of the owner's stake, adjusted for the impact of issuance. The negative trend here confirms a stage of planned liquidity expenditure.